|
[posting]60589011[/posting] bereits gezahlt wurden: US$200,000 upon the signing of this agreement (paid in F2014 and recorded as revenue); US$300,000 upon successful completion of the first line test (paid in F2016 and recorded as revenue); US$500,000 upon successful filing of IND application under CFDA US$500,000 upon receipt of CTA by CFDA for a Phase I study in the territory offen sind noch: US$1,500,000 upon receipt of CTA by CFDA for a Phase III study; US$2,500,000 upon successful completion of a first Phase III study; US$4,000,000 upon NDA approval by CFDA in the territory; Running royalties of 5% on product net sales during the royalty period. |
|
| aus der Diskussion: | Sirona Biochem |
| Autor (Datum des Eintrages): | freixenetter (17.05.19 12:41:57) |
| Beitrag: | 10,574 von 31,047 (ID:60589995) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |